Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 9,365 | 5,973 | 21,143 | 15,362 | 15,656 |
| Cost of Goods | 1,370 | 2,250 | 8,040 | 6,630 | 4,870 |
| Gross Profit | 7,980 | 3,710 | 13,120 | 8,730 | 10,770 |
| Operating Expenses | 12,060 | 12,210 | 6,940 | 12,080 | 8,570 |
| Operating Income | -3,695 | -8,237 | 6,203 | -2,718 | 3,086 |
| Interest Expense | 230 | 210 | -210 | 180 | 340 |
| Other Income | 1,885 | 777 | 847 | 298 | 604 |
| Pre-tax Income | -2,040 | -7,670 | 7,260 | -2,600 | 3,350 |
| Income Tax | -790 | -3 | 3,010 | 270 | 1,470 |
| Net Income Continuous | -1,630 | -5,613 | 2,000 | -2,142 | 1,878 |
| Net Income | $-1,630 | $-5,613 | $2,000 | $-2,142 | $1,878 |
| EPS Basic Total Ops | -0.02 | -0.10 | 0.05 | -0.04 | 0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.10 | 0.04 | -0.04 | 0.03 |
| EPS Diluted Total Ops | -0.03 | -0.10 | 0.05 | -0.04 | 0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.10 | 0.04 | -0.04 | 0.03 |
| EBITDA(a) | $-2,395 | $-6,987 | $7,413 | $-1,698 | $3,086 |